Investing Profile

Martin Heidecker

InvestorVC
Chief Investment Officer at AMR Actions Fund
amractionfund.comCambridge, Massachusetts
Photo of Martin Heidecker, Investor at AMR Action Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
9
$1B
CompanyStageDateRound SizeTotal Raised
Vedanta Biosciences
Series EApr 2023$110M
$110M
Co-investors: Curt LaBelle (Adjuvant Capital)
BioVersys
Series CJan 2023$9M
$9M
Venatorx Pharmaceuticals
Series CApr 2022$34M
$76M
Co-investors: Brett Zbar (General Atlantic), Carlo Rizzuto (Versant Ventures)
Adaptive Phage Therapeutics
Series BApr 2022$20M
$61M
Co-investors: Jonathan Leff (Deerfield Management)
Libra Therapeutics
Series ASep 2020$29M
$29M
Rgenta Therapeutics
SeedApr 2020$20M
$90M
Co-investors: Fei Shen (Boehringer Ingelheim Venture Fund), Hongbo Lu (Vivo Capital)
Sentien Biotechnologies
Series AApr 2017$12M
$12M
Co-investors: Johannes Fruehauf (Mission BioCapital)
Sentieon
Series AApr 2014$4M
$4M
Co-investors: Johannes Fruehauf (Mission BioCapital)